Gastric Adenocarcinomas with CDX2 Induction Show Higher Frequency of TP53 and KMT2B Mutations and MYC Amplifications but Similar Survival Compared with Cancers with No CDX2 Induction
Ioannis A. Voutsadakis · 2024
Read Gastric Adenocarcinomas with CDX2 Induction Show Higher Frequency of TP53 and KMT2B Mutations and MYC Amplifications but Similar Survival Compared with Cancers with No CDX2 Induction by Ioannis A. Voutsadakis (2024) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11727917.txt.
Description
Ioannis Voutsadakis, a solo author, compares two kinds of stomach cancer in a 2024 paper. Some of these cancers switch on a gene more typical of the gut, which may mark a distinct subtype. Using a large public cancer dataset, he split tumors by whether that gene was active and compared their traits.
Patients with the gene active were older and had less of one tissue type. Their tumors more often carried changes in two named genes and extra copies of a third. Survival, both overall and without the disease worsening, was about the same in both groups. The author says the subtype's distinct traits could matter for future treatment choices.
Catalog record
| CREATOR | Ioannis A. Voutsadakis |
|---|---|
| YEAR | 2024 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 34 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |